Selective CD117+ HSC exchange therapy
- PMID: 31072963
- DOI: 10.1182/blood-2019-03-900894
Selective CD117+ HSC exchange therapy
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Comment on
-
Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice.Blood. 2019 May 9;133(19):2069-2078. doi: 10.1182/blood-2018-06-858159. Epub 2019 Feb 11. Blood. 2019. PMID: 30745302 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

